These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 1713408

  • 1. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
    Bonkovsky HL, Healey JF, Lourie AN, Gerron GG.
    Am J Gastroenterol; 1991 Aug; 86(8):1050-6. PubMed ID: 1713408
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E, Harper P, Andersson DE, Floderus Y.
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [Abstract] [Full Text] [Related]

  • 6. Elevated brain tryptophan and enhanced 5-hydroxytryptamine turnover in acute hepatic heme deficiency: clinical implications.
    Litman DA, Correia MA.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):337-45. PubMed ID: 3968635
    [Abstract] [Full Text] [Related]

  • 7. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
    Wang B, Bonkovsky HL, Lim JK, Balwani M.
    Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatic alteration of tryptophan metabolism in an acute porphyria model Its relation with gluconeogenic blockage.
    Lelli SM, Mazzetti MB, San Martín de Viale LC.
    Biochem Pharmacol; 2008 Feb 01; 75(3):704-12. PubMed ID: 17996218
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical and laboratory findings concerning at first dietary and afterwards cimetidine treatment of acute intermittent porphyria].
    Gullotti D, Schillaci L, Amato S, Salerno L.
    Clin Ter; 1994 Aug 01; 145(8):123-9. PubMed ID: 7955957
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Porphyrin synthesis and mitochondrial respiration in acute intermittent porphyria: studies using cultured human fibroblasts.
    Bonkowsky HL, Tschudy DP, Weinbach EC, Ebert PS, Doherty JM.
    J Lab Clin Med; 1975 Jan 01; 85(1):93-102. PubMed ID: 1141734
    [Abstract] [Full Text] [Related]

  • 14. [Hemin treatment in a case of porphyria variegata].
    Adam C, Hassoun A, Defresne C, Guilmot-Bruneau M, Wery-Follet B, Saussez-De Temmerman A.
    Dermatologica; 1982 Jan 01; 165(6):640-6. PubMed ID: 7169140
    [Abstract] [Full Text] [Related]

  • 15. Herbicide-induced experimental variegate porphyria in mice: tissue porphyrinogen accumulation and response to porphyrogenic drugs.
    Krijt J, Stranska P, Maruna P, Vokurka M, Sanitrak J.
    Can J Physiol Pharmacol; 1997 Jan 01; 75(10-11):1181-7. PubMed ID: 9431441
    [Abstract] [Full Text] [Related]

  • 16. Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries.
    Prabahar MR, Manorajan R, Sathiyakumar D, Soundararajan P, Jayakumar M.
    Hemodial Int; 2008 Jan 01; 12(1):34-8. PubMed ID: 18271838
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of hematin in acute porphyric relapse].
    Monsalve V, Wolff C, Gómez R, Armas Merino R, Canals C.
    Rev Med Chil; 1979 Jan 01; 107(1):38-41. PubMed ID: 462025
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.